lower risk – Page 5 – Communicable Diseases Research

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada

Research

Published on 2022-06-242022-10-05
Journal: Scientific Reports [Category] COVID19(2023년), SARS, 임상,

Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)

헝가리의 델타 및 오미크론 대유행 기간 동안 1차 및 2차 SARS-CoV2 부스터 백신의 전국적인 효과(HUN-VE 2 연구)

Observational Study

Published on 2022-06-232022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단,

[키워드] 4th vaccine 95% CI 95% confidence interval B.1.617.2 benefit booster booster dose booster vaccination Booster vaccine booster vaccines control group COVID-19 related mortality death Delta delta variant Delta variant (B.1.617.2) Delta wave demonstrated dose Effectiveness examined groups Hungary immunization immunized lower risk Mortality offered Older age omicron Omicron variant omicron variant (SARS-CoV-2) pandemic rate ratio risk SARS-COV-2 infection SARS-CoV-2 variants SARS-CoV2 SARS-CoV2 infection second significantly lower study population Vaccine vaccine effectiveness variant vulnerable population Wave
[DOI] 10.3389/fimmu.2022.905585 PMC 바로가기 [Article Type] Observational Study

Using data from a private provider of telemedicine to assess the severity of the early 2021 Covid-19 wave in Brazil

원격 의료 민간 제공업체의 데이터를 사용하여 브라질의 2021년 초반 Covid-19 물결의 심각성을 평가

Article

Published on 2022-06-222022-09-11
Journal: Brazilian Journal of Medical and Biological Resear [Category] COVID19(2023년), SARS, 변종,

Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)

Observational Study

Published on 2022-06-082022-10-05
Journal: BMC primary care [Category] COVID19(2023년), SARS, 임상,

[키워드] 95% CI age age and gender analyzed Anticoagulant applied Care Cohort Comorbidity Complication COVID-19 COVID-19 complication database death Diagnosis Electronic health records events Frequency group had more Health higher risk Hospital admission Hospitalization Hospitalized increased risk individuals with COVID-19 Intervention lower risk mortality rate not different OAC Observational cohort study Older oral oral anticoagulant Oral anticoagulants outcome Patient Pneumonia Primary Health Care propensity score matching risk Spain stroke System Thromboembolic event Thromboembolic events thrombotic event Thrombotic events treated with COVID-19 women
[DOI] 10.1186/s12875-022-01752-5 PMC 바로가기 [Article Type] Observational Study

Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England

어린이의 SARS-CoV-2 재감염 위험: 영국에서 2020년 1월과 2021년 7월 사이의 전향적 국가 감시 연구

Article

Published on 2022-06-012022-09-11
Journal: The Lancet. Child & adolescent health [Category] COVID19(2023년), SARS, 변종,

Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study

델타 대 오미크론 COVID-19 변종에 감염된 환자 파리 응급실에 내원한 비교 : 후향적 코호트 연구

Article

Published on 2022-06-012022-09-11
Journal: Annals of internal medicine [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI adjusted Admission age B.1.1.529 B.1.617.2 baseline baseline characteristics biological pattern Chain Reaction Characteristics COVID-19 COVID-19 illness Delta delta variant Department discharge home dose doses Dyspnea Emergency emergency department hospital ICU ICU admission In-hospital in-hospital mortality Infection intensive care intensive care unit lower risk mechanical ventilation median age obesity omicron Omicron variant outcome outcome measure outcomes Paris Patient patients with SARS-CoV-2 PCR test polymerase chain polymerase chain reaction positive positive reverse transcriptase polymerase chain reaction positive RT-PCR reverse transcriptase RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant study period survival test result transcriptase variant were excluded with COVID-19 women
[DOI] 10.7326/M22-0308 PMC 바로가기 [Article Type] Article

Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection

이전 SARS-CoV-2 감염 여부에 관계없이 개인 간의 코로나19 백신 접종 후 부작용 및 의료 이용

Article

Published on 2022-06-012022-09-11
Journal: Journal of internal medicine [Category] COVID19(2023년), SARS, 치료기술,

Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients

노르웨이의 COVID-19 환자의 입원 기간 및 중환자실 입원 및 병원 내 사망 위험: mRNA 백신으로 완전히 예방접종을 받은 환자와 예방접종을 받지 않은 환자를 비교한 등록 기반 코호트 연구

Article

Published on 2022-06-012022-09-11
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI adjusted Admission age analyzed Birth Breakthrough infection cohort study country COVID-19 patient Cox proportional hazard Cox proportional hazards models dose hazard ratio Health authority hospital Hospital stay Hospitalization Hospitalized hospitals ICU ICU admission In-hospital In-hospital death intensive care intensive care unit Length Length of stay log lower risk management median mRNA vaccine National no difference Norway Patient Patient management patients patients hospitalized registry data residence risk Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-positive patient SARS-CoV-2-positive patients Sex Support vaccination Vaccination Status variant virus with COVID-19
[DOI] 10.1016/j.cmi.2022.01.033 PMC 바로가기 [Article Type] Article

An assessment of the vaccination of school-aged children in England against SARS-CoV-2

SARS-CoV-2에 대한 영국의 취학 연령 아동 예방 접종 평가

Article

Published on 2022-05-182022-09-11
Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종,

[키워드] adverse event adverse events age Analysis assumed average benefit childhood children Cohort COVID-19 death deaths delta variant Efficacy England Evidence expansion facilitate generate greater group Health hospital Hospital admission Hospital admissions immunisation individual Infection interactions involved knowledge less lower risk mathematical mathematical model Measures projection public health reduced reduction reduction in Relaxation reported resource SARS-CoV-2 Spread substantial reduction substantial reductions suggested the vaccine vaccination Vaccine vaccine administration vaccine efficacy with infection
[DOI] 10.1186/s12916-022-02379-0 PMC 바로가기 [Article Type] Article

At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers

재택 검체 채취는 유증상 및 무증상 SARS-CoV-2 보균자의 진단 및 관리를 위한 효과적인 전략입니다.

Article

Published on 2022-05-092022-09-11
Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 치료기술,

[키워드] 95% CI Adults Analysis Asymptomatic Asymptomatic cases average carrier case-control study Collection Community COVID-19 cross-sectional determine Diagnosis diagnostic testing disease effective handling home humans individual lower risk management molecular nasal swab National no symptom no symptoms participant PCR test positive positive test result Prevalence prevalence of COVID-19 provide Relative risk retrospective risk risk ratio RT-PCR test SARS-CoV-2 SARS-CoV-2 tests self-reported symptom Self-reported symptoms specimen handling Symptom symptomatic and asymptomatic symptomatic individual symptomatic individuals the United State Transmission transmission of SARS-CoV-2 United States
[DOI] 10.1186/s12879-022-07377-4 PMC 바로가기 [Article Type] Article